ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984

Knowing Tumor Cell Structure Improves Treatment Decisions

March 27, 2009

In Brief: Ed Moorhead, Community Cancer program Leader, Dies At Age 50; Ficca Appointed NHLBI AO

February 6, 1987